A Phase I Study of SRG-514 Administered Intraoperatively to the Site of Tumor Resection of Patients undergoing Breast-Conserving Cancer Surgery (SRG-514-01)
Clinical Trial Grant
Administered By
Surgical Oncology
Awarded By
Surge Therapeutics
Start Date
July 1, 2024
End Date
June 30, 2029
Administered By
Surgical Oncology
Awarded By
Surge Therapeutics
Start Date
July 1, 2024
End Date
June 30, 2029